New Research Demonstrates Synergy Between Light Therapy and Chemotherapy, According to Surviving Mesothelioma

Share Article

Researchers in Korea have published details of a mesothelioma patient who survived more than twice as long as the average after receiving a treatment combination including photodynamic therapy.

PDT and Chemotherapy Treat Mesothelioma Synergistically

Light-Based Therapy for Mesothelioma

The patient showed a survival time of 27 months, which is longer than median survival time in advanced mesothelioma patients.

Doctors in Cheonan, Korea claim that their new mesothelioma case report shows how photodynamic therapy enhances the effectiveness of chemotherapy. Click here to read the full story on the Surviving Mesothelioma website.

Scientists at Dankook University College of Medicine treated a 68-year-old mesothelioma patient with chemotherapy and photodynamic therapy, a treatment that makes cancer cells susceptible to damage from light. The results suggest that there may be a synergistic effect between the two.

“The patient showed a survival time of 27 months, which is longer than median survival time in advanced mesothelioma patients,” write Drs. Ryu and Kim who authored the report.

According to the article in a Seoul-based medical journal, the patient received photodynamic therapy (also called PDT) both after and before rounds of platinum-based chemotherapy.

“We think this case is notable because the life expectancy for someone with advanced mesothelioma would normally be less than a year,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “At the very least, this is an indication that more PDT research is warranted for mesothelioma.”

To read the exact treatment protocol that allowed the Korean mesothelioma patient to survive for more than two years, see Light-Based Therapy Leads to Longer Survival in Korean Mesothelioma Patient, now available on the Surviving Mesothelioma website.

Ryu, JW and Kim, YS, “A case of advanced malignant pleural mesothelioma treatment with chemotherapy and photodynamic therapy,” January 2015, Tuberculosis and Respiratory Diseases, http://www.ncbi.nlm.nih.gov/pubmed/25653696

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website